DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

<p><strong>Objective:</strong> The main purpose of this study is to evaluate the potential clinical impact of pharmacogenetic testing on the reduction of the toxicity in patients treated with fluoropyrimidines. This will be achieved by comparing the frequency of adverse events...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Ana Hernández-Guío, M.ª Ángeles Bernabéu-Martínez, Andrés Corno-Caparrós, M.ª Teresa Aznar-Saliente, Manuel Bonete-Sánchez, Miguel Ángel Calleja-Hernández
Materialtyp:	Artikel
Språk:	English
Publicerad:	Elsevier 2021-05-01
Serie:	Farmacia Hospitalaria
Ämnen:	clinical protocols precision medicine fluoropyrimidines pharmacogenetics toxicity genetic polymorphism dpyd dihydropyrimidine dehydrogenase
Länkar:	http://www.aulamedica.es/fh/pdf/11607.pdf

Liknande verk

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD
av: Jonathan E. Knikman, et al.
Publicerad: (2024-08-01)

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
av: Chi C. Tong, et al.
Publicerad: (2018-07-01)

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol
av: Cassandra White, et al.
Publicerad: (2024-11-01)

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study
av: Paula Soria-Chacartegui, et al.
Publicerad: (2021-11-01)

Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature
av: Nedal Bukhari, et al.
Publicerad: (2021-07-01)

A novel large intragenic DPYD deletion causing dihydropyrimidine dehydrogenase deficiency: a case report
av: Anna Malekkou, et al.
Publicerad: (2024-03-01)

Investigation of Ivs14+1G>A Polymorphism of Dpyd Gene in a Group of Bosnian Patients Treated with 5-Fluorouracil and Capecitabine
av: Timur Cerić, et al.
Publicerad: (2010-05-01)

<i>DPYD</i> Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation
av: Theodore J. Wigle, et al.
Publicerad: (2023-01-01)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
av: Angela Wu, et al.
Publicerad: (2023-09-01)

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre
av: David K. Lau, et al.
Publicerad: (2023-04-01)

Potential Impact of DPYD Variation on Fluoropyrimidine Drug Response in sub-Saharan African Populations
av: Jorge E. B. da Rocha, et al.
Publicerad: (2021-03-01)

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of <i>DPYD</i> Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study
av: Xando Díaz-Villamarín, et al.
Publicerad: (2024-07-01)

Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population
av: Masashi Kanai, et al.
Publicerad: (2023-04-01)

<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
av: Theodore J. Wigle, et al.
Publicerad: (2019-05-01)

Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population
av: Eiji Hishinuma, et al.
Publicerad: (2022-06-01)

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature
av: White C, et al.
Publicerad: (2021-12-01)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
av: Ursina B. M. Begré, et al.
Publicerad: (2022-05-01)

The Frequency of <i>DPYD</i> c.557A>G in the Dominican Population and Its Association with African Ancestry
av: Mariela Guevara, et al.
Publicerad: (2024-12-01)

Clinical implications of a gain-of-function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines
av: Elena De Mattia, et al.
Publicerad: (2024-12-01)

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
av: Georgia Ragia, et al.
Publicerad: (2023-09-01)

Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving Fluorouracil
av: Lauren E. Winquist, et al.
Publicerad: (2020-12-01)

Three different polymorphisms of the DPYD gene associated with severe toxicity following administration of 5-FU: a case report
av: Deborah Mukherji, et al.
Publicerad: (2019-03-01)

Upfront <i>DPYD</i> Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress
av: Antoine Desilets, et al.
Publicerad: (2022-01-01)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
av: Anthi Maslarinou, et al.
Publicerad: (2023-05-01)

Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients
av: Alessio Ardizzone, et al.
Publicerad: (2024-09-01)

Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics
av: Annalaura Montella, et al.
Publicerad: (2024-04-01)

High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity
av: Emma eBorràs, et al.
Publicerad: (2013-01-01)

Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment
av: Ana Hernández-Guío, et al.
Publicerad: (2024-12-01)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
av: Raffaele Palmirotta, et al.
Publicerad: (2019-03-01)

Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
av: A. Bignucolo, et al.
Publicerad: (2023-05-01)

Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation
av: K. B. Mirzaev, et al.
Publicerad: (2020-09-01)

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
av: García-González X, et al.
Publicerad: (2018-10-01)

The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer
av: Hiroyuki Kato, et al.
Publicerad: (2024-08-01)

Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy
av: Seid Hamzic, et al.
Publicerad: (2020-11-01)

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing
av: Lisa A. Varughese, et al.
Publicerad: (2022-07-01)

ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study
av: Lennard Y. W. Lee, et al.
Publicerad: (2019-10-01)

Dihydropyrimidine dehydrogenase level and the redox status in patients with colorectal cancer are prognostic for adverse effects of fluoropyrimidines
av: Nadya G. Hristova-Avakumova, et al.
Publicerad: (2021-01-01)

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
av: Linda Cucciniello, et al.
Publicerad: (2022-09-01)

Relationship Between Dihydropyrimidine Dehydrogenase Gene Polymorphism and Toxicities in Cancer Patients Receiving 5-Fluorouracil
av: Tahsin YÜKSEL, et al.
Publicerad: (2024-08-01)

Implementation of DPYD testing in Bulgarian patients with cancer
av: Nelly Miteva-Marcheva, et al.
Publicerad: (2024-12-01)